Richard Giroux is currently serving as the Chief Operating Officer at MeiraGTx since April 2015. Prior to their current role, Richard was a Partner at Meadowvale Partners from 2009 to 2013 and at Sivik Global Healthcare from 2001 to 2008. Richard also has experience in Equity Derivatives from their time at Goldman Sachs and SALOMON SMITH BARNEY. Richard obtained their Bachelor's degree in Economics from Yale University in 1995.
MeiraGTx
2 followers
MeiraGTx, a New York and London-based company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders.